Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-02 Sale | 2025-07-03 4:07 pm | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, Chief Accounting Officer | 2,503 | $9.95 | $24,905 | 57,137 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:23 pm | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, Chief Accounting Officer | 1,372 | $12.18 | $16,711 | 45,640 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 5:29 pm | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, Chief Accounting Officer | 2,012 | $19.01 | $38,248 | 47,012 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-01 Option Award | 2025-03-04 4:28 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, Chief Accounting Officer | 14,000 | $0 | 59,640 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 1:15 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, PAO and Interim PFO | 17,801 | $0 | 49,024 (Direct) | View |
Ownership | 2024-04-22 4:10 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Dube Michael P Principal Accounting Officer | 0 | $0 | 31,223 (Direct) | View |